Press Releases

Date Title and Summary View
Toggle Summary NxStage Announces Significant Increase in Nx2me Connected Health® Platform Adoption
Momentum Reflects Platform's Ability to Improve Patient Retention with Home Hemodialysis LAWRENCE, Mass. , Oct. 26, 2018 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the number of home hemodialysis
View HTML
Toggle Summary New Study Showcases Improved Survival With More Frequent Home Hemodialysis in Incident Dialysis Patients
Patients 20-44 years of age experienced 44% lower risk of death LAWRENCE, Mass. , Oct. 23, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced a new study highlighting significant improvements in first-year
View HTML
Toggle Summary New Data Demonstrates Significant Survival Benefit with More Frequent Hemodialysis Using the NxStage System One in Skilled Nursing Facility Setting
More frequent on-site home hemodialysis reduced the risk of death by one third and reduced the risk of cardiovascular hospitalization by 23% LAWRENCE, Mass. , Oct. 18, 2018 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care ,
View HTML
Toggle Summary Medisystems Announces US Release of MasterGuard® Plus
Innovative AVF needle guard includes enhancements designed to prevent needlesticks LAWRENCE, Mass. , April 13, 2018 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that its Medisystems products division has
View HTML
Toggle Summary NxStage Celebrates Fifth Annual National Home Hemodialysis Day
Company lights Boston's Zakim Bridge and boosts educational awareness efforts on the benefits of home hemodialysis and more frequent therapy. LAWRENCE, Mass. , March 15, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), the manufacturer of the NxStage® System One™ home hemodialysis system,
View HTML
Toggle Summary Seven Unique NxStage Abstracts Presented During the 38th Annual Dialysis Conference
LAWRENCE, Mass. , March 13, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings further demonstrating the benefits of home hemodialysis with the NxStage® System One™, including on-site hemodialysis
View HTML
Toggle Summary NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants
LAWRENCE, Mass. , Dec. 11, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , celebrates the achievement of over five thousand patients having received a kidney transplantation after performing more frequent home
View HTML
Toggle Summary Nx2me Connected Health® Improves Home Hemodialysis Retention
LAWRENCE, Mass. , Dec. 7, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new results in Hemodialysis International , demonstrating its remote patient management system, Nx2me Connected Health , reduces
View HTML
Toggle Summary Eleven Unique NxStage Abstracts Accepted for 2017 Kidney Week
New studies being showcased at the American Society of Nephrology Congress confirm interim results from FREEDOM study and present new data on therapy retention and graduation rates.
View HTML
Toggle Summary NxStage Announces Stockholder Approval Of Merger Agreement With Fresenius Medical Care
LAWRENCE, Mass. , Oct. 27, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that at a special meeting of stockholders held today, the Company's stockholders voted to adopt the previously announced
View HTML